Endra Life Sciences Amends Merger Agreement
Endra Life Sciences amended its merger agreement with Renergen Limited effective Oct. 1, 2026. The amendment adjusted board structures and closing terms, while also allowing the parties to update financial and capital management documents.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed